Loading clinical trials...
Loading clinical trials...
A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age After the Fontan Procedure
Conditions
Interventions
Rivaroxaban
Acetylsalicylic Acid
Locations
42
United States
Los Angeles, California, United States
Gainesville, Florida, United States
Oak Lawn, Illinois, United States
Indianapolis, Indiana, United States
Iowa City, Iowa, United States
Baltimore, Maryland, United States
Start Date
November 16, 2016
Primary Completion Date
July 16, 2020
Completion Date
July 16, 2020
Last Updated
March 30, 2025
NCT07410117
NCT03830320
NCT07102160
NCT06658197
NCT05628948
NCT05967741
Lead Sponsor
Janssen Research & Development, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions